LABA and LAMA are used to relieve the symptoms of ... AstraZeneca), which are ICS–LABA combinations, are other popular COPD drugs. A major limitation with the current corticosteroid therapy ...

Current evidence supports existing treatment guidelines advocating LABDs (LAMA, LABA) as first-line therapy for COPD, with regular ICS therapy as an adjunct in COPD patients experiencing frequent ...

Further, if initial pharmacotherapy with LABA or LAMA after a COPD exacerbation ... that rates of adherence to inhaled medication are low for patients with COPD, even among patients with severe ...

At the moment, the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), a long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA), or LABA/LAMA dual ...

A new study suggests COPD patients experience ... The CRYSTAL study is the first LABA/LAMA pragmatic trial, designed to mimic clinical practice, so treatment switching occurred without a washout ...